Clinical

Atopic dermatitis is a chronic inflammatory skin disease that is characterized by intense itch and acute, subacute, or chronic eczematous skin lesions. The disease course can be chronic or relapsing­remitting. Lesions typically present with an age-related morphology and distribution.
Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges
Academic detailing, a means of providing educational outreach to providers, has been described as a face-to-face interactive encounter between a healthcare provider and a clinical educator who is trained in social marketing and motivational interviewing skills to deliver actionable key messages in the privacy of providers’ offices.
Collaborative drug therapy management protocols are defined and written agreements between pharmacists and providers that allow pharmacists to optimize medication therapy management for individual patients.
Collaborative Efforts Help the Avoidance of Diabetes Mismanagement
Rheumatoid arthritis (RA) is a chronic systemic inflammatory condition that negatively affects the physical and mental health of individuals.
Comorbidities in Rheumatoid Arthritis Present Clinical, Economic Challenges for All Stakeholders
Drug therapy problems, which are undesirable events that involve medications that can ultimately interfere with a patient’s therapeutic goals, are a major cause of morbidity, mortality, and hospitalizations in older adults.
Improving the Outcomes of Medication Use by Seniors
Cataracts are the leading cause of preventable blindness globally and are responsible for approximately 50% of worsening bilateral vision cases among Caucasians, Hispanics, and African Americans in the United States.
Engaging Patients in Decision-Making for Psoriatic Arthritis Treatment
Immunoglobulin light-chain amyloidosis (AL amyloid­osis), one of the most common forms of amyloidosis, is a rare and typically fatal disease caused by misfolded light chains—protein chains formed by plasma cells that misfold into an abnormal shape—that form soluble toxic aggregates and deposit fibrils (amyloid) in organs.
Preliminary results of this study were presented as a poster at the American Society of Health-System Pharmacists 2017 Summer Meetings and Exhibition.
Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage
In the United States, more than 80% of all patients with end-stage renal disease (ESRD) initiate dialysis with hemodialysis, and current reports indicate that this trend has changed little over the past 2 decades.
The Challenge of Maintaining Vascular Access in Patients with End-Stage Renal Disease
Page 1 of 13
Results 1 - 10 of 122
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME